Aging Journal News

Mikhail Blagosklonny
Mikhail Blagosklonny

ABOUT Dr. Mikhail (Misha) Blagosklonny:

It is with great sadness and heavy heart that we announce the recent passing of Dr. Mikhail (Misha) V. Blagosklonny, our beloved Editor-in-Chief. Misha succumbed to metastatic lung cancer after a courageous battle.

Dr. Blagosklonny will be remembered as a brilliant and extraordinary scientist who dedicated his life to science. He was a visionary thinker, who made highly original contributions to cancer and aging research that were often ahead of their time.

Dr. Blagosklonny was born into a family of scientists. His mother, Professor of Medicine Yanina V. Blagosklonnaya, specialized in endocrinology and was a talented teacher, mentoring several generations of medical students. His father, Professor Vladimir M. Dilman, was a brilliant gerontologist, endocrinologist and oncologist, known for being a very charismatic person. He was the first person to encourage Misha to think about nature, aging, and philosophy.

Misha was a theorist by nature. While in school, he was deeply interested in physics and dreamed of becoming a theoretical physicist. Eventually, he chose biology, driven to study aging and age-related diseases, including cancer. He started as an experimentalist, but over the years, he became a theoretical biologist. In a way, his dream came true. 

Read the full tribute to Dr. Blagosklonny | @Blagosklonny

ABOUT MishaBlagosklonny.com:

Read the latest news about recent and trending scientific papers published by Aging—a rigorously peer-reviewed open-access bi-monthly scientific journal. The Aging Journal focuses on publishing high-quality literature from researchers striving to better understand the intricate nature of the human aging process.

The mission of the journal is to understand the mechanisms surrounding aging and age-related diseases, including cancer as the main cause of death in the modern aged population.

The journal aims to promote 1) treatment of age-related diseases by slowing down aging, 2) validation of anti-aging drugs by treating age-related diseases, and 3) prevention of cancer by inhibiting aging. (Cancer and COVID-19 are age-related diseases.)

Impact Journals (Aging‘s publishers) meets the standards of the Wellcome Trust Publisher Requirements and was included into the Wellcome Trust List of Compliant Publishers. Read about our rigorous Scientific Integrity Process.

To learn more, please visit Aging-us.com or follow @AgingJrnl on X and @AgingUS on Facebook.

Aging Scientific Integrity
Aging Scientific Integrity

Comments are closed.

  • Follow Us